On the other hand, the number of IL-22+ TILs from the melanoma samples was higher than that of the PBMC (1.8% ± 0.3) and analogous to the number of IL-22+ TILs isolated from BCC samples (9.6% ± 1.3) (Figure 1E). The gene discussed is IL22; the disease is skin basal cell carcinoma.